CN Patent

CN107737100A — 苯二氮卓组合物的投与

Assigned to Shenzhen Kangzhe Biotechnology Co ltd · Expires 2018-02-27 · 8y expired

What this patent protects

本发明涉及苯二氮卓组合物的投与，以及供经鼻投与的医药组合物、制造和使用所述组合物的方法，所述医药组合物包含一种或一种以上苯二氮卓药物。

USPTO Abstract

本发明涉及苯二氮卓组合物的投与，以及供经鼻投与的医药组合物、制造和使用所述组合物的方法，所述医药组合物包含一种或一种以上苯二氮卓药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN107737100A
Jurisdiction
CN
Classification
—
Expires
2018-02-27
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Kangzhe Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.